Orthofix Medical (OFIX) Cash & Current Investments (2016 - 2026)
Orthofix Medical has reported Cash & Current Investments over the past 18 years, most recently at $120.9 million for Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 99.94% year-over-year to $120.9 million, compared with a TTM value of $120.9 million through Mar 2026, up 99.94%, and an annual FY2025 reading of $85.1 million, down 0.73% over the prior year.
- Cash & Current Investments came in at $120.9 million for Q1 2026, up from $85.1 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $120.9 million in Q1 2026 to a low of $28.9 million in Q2 2024.
- Median Cash & Current Investments over the past 5 years was $51.7 million (2022), compared with a mean of $57.1 million.
- The sharpest move saw Cash & Current Investments crashed 42.29% in 2022, then soared 137.96% in 2025.
- Over 5 years, Cash & Current Investments stood at $50.7 million in 2022, then dropped by 25.53% to $37.8 million in 2023, then skyrocketed by 127.08% to $85.7 million in 2024, then decreased by 0.73% to $85.1 million in 2025, then skyrocketed by 42.01% to $120.9 million in 2026.
- Per Business Quant, the three most recent readings for OFIX's Cash & Current Investments are $120.9 million (Q1 2026), $85.1 million (Q4 2025), and $65.9 million (Q3 2025).